MedTrace Logo

Patient Factors Impacting Adherence to Oral Chemotherapy

NCT01487343 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2016-11-08

No results posted yet for this study

Summary

The purpose of this study is to identify what makes it easier and what makes it harder to take oral chemotherapy.

Conditions

Interventions

BEHAVIORAL

questionnaire and interview

Interviews will be conducted with the first 10 participants who agree to be interviewed (or until data saturation is reached). Self-report questionnaires assessing adherence, beliefs about medications, side effect experience, self-efficacy, and satisfaction with patient education; the qualitative portion is an interview guided by two open-ended questions. Data will be collected approximately 2 weeks - 6 months (2 - 24 weeks) after being prescribed capecitabine.

Sponsors & Collaborators

Principal Investigators

  • Pamela Ginex, EdD, RN, OCN · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01487343 on ClinicalTrials.gov